These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 22148915)

  • 1. Distinct urinary metabolic profile of human colorectal cancer.
    Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
    J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabonomic study on colorectal cancer.
    Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
    J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
    Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
    J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urinary metabonomic study of human osteosarcoma.
    Zhang Z; Qiu Y; Hua Y; Wang Y; Chen T; Zhao A; Chi Y; Pan L; Hu S; Li J; Yang C; Li G; Sun W; Cai Z; Jia W
    J Proteome Res; 2010 Sep; 9(9):4861-8. PubMed ID: 20690664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
    Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
    J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer detection using targeted serum metabolic profiling.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Chiorean EG; Raftery D
    J Proteome Res; 2014 Sep; 13(9):4120-30. PubMed ID: 25126899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
    Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
    Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
    Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
    Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
    Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].
    Ma YL; Liu WJ; Peng JY; Zhang P; Chen HQ; Qin HL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):386-90. PubMed ID: 19598026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary metabolic profiling of colorectal carcinoma based on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry.
    Wang W; Feng B; Li X; Yin P; Gao P; Zhao X; Lu X; Zheng M; Xu G
    Mol Biosyst; 2010 Oct; 6(10):1947-55. PubMed ID: 20617254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.